Abstract
Non-small-cell lung cancer (NSCLC) is currently the neoplasm leading in deaths worldwide and in Brazil it figures as the second most common cancer in terms of number of deaths. Patients are usually diagnosed in advanced stages and, consequently, more than 45% of all patients are diagnosed with cachexia, characterized by a severe loss of muscle mass with or without fat loss. This syndrome …